Notice
DATE2026.07.27
VIEWS331
KoreaBIO, in collaboration with the K-BD Network, is pleased to announce the 3rd Dealmaker Academy of 2026, a program designed to strengthen global business development(BD) capabilities and foster meaningful connections among biotech and pharma professionals.
The theme of this seminar is "Turning Basic Research into Global Deals: Drug Discovery and Development Strategies"
Participants will gain insights into how global pharmaceutical companies evaluate potential assets from an in-licensing perspective, while exploring translational research strategies and AI-powered biomarker development.
■ Overview
● Participation Fee: Free of charge (including the networking reception). Participants interested in attending the networking session will be given priority during the selection process.
* For more details, please refer to the poster and registration link below.
- Application Deadline: Friday, August 7, 2026
- Selected participants will be notified individually via email on August 14, 2026.






